81 related articles for article (PubMed ID: 21276122)
1. A randomized controlled trial of lycopene treatment on soluble receptor for advanced glycation end products in seminal and blood plasma of normospermic men.
Oborna I; Malickova K; Fingerova H; Brezinova J; Horka P; Novotny J; Bryndova H; Filipcikova R; Svobodova M
Am J Reprod Immunol; 2011 Sep; 66(3):179-84. PubMed ID: 21276122
[TBL] [Abstract][Full Text] [Related]
2. The effects of dietary lycopene supplementation on human seminal plasma.
Goyal A; Chopra M; Lwaleed BA; Birch B; Cooper AJ
BJU Int; 2007 Jun; 99(6):1456-60. PubMed ID: 17484766
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for advanced glycation end products in male infertility.
Charalampidou S; Simitsopoulou Μ; Skoura L; Tziomalos K; Koulourida V; Goulis DG
Hippokratia; 2017; 21(1):19-24. PubMed ID: 29904252
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum and seminal plasma zinc levels and serum testosterone in oligospermic and azoospermic infertile men.
Ali H; Baig M; Rana MF; Ali M; Qasim R; Khem AK
J Coll Physicians Surg Pak; 2005 Nov; 15(11):671-3. PubMed ID: 16300697
[TBL] [Abstract][Full Text] [Related]
6. Lycopene improves the distorted ratio between AA/DHA in the seminal plasma of infertile males and increases the likelihood of successful pregnancy.
Filipcikova R; Oborna I; Brezinova J; Novotny J; Wojewodka G; De Sanctis JB; Radova L; Hajduch M; Radzioch D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):77-82. PubMed ID: 23446211
[TBL] [Abstract][Full Text] [Related]
7. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
8. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
9. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation.
Kalousová M; Bartosová K; Zima T; Skibová J; Teplan V; Viklický O
Kidney Blood Press Res; 2007; 30(1):31-7. PubMed ID: 17237617
[TBL] [Abstract][Full Text] [Related]
11. Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis.
Chayanupatkul M; Honsawek S
Clin Biochem; 2010 Sep; 43(13-14):1133-7. PubMed ID: 20627100
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
[TBL] [Abstract][Full Text] [Related]
13. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats.
Ateşşahin A; Karahan I; Türk G; Gür S; Yilmaz S; Ceribaşi AO
Reprod Toxicol; 2006 Jan; 21(1):42-7. PubMed ID: 15979841
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
15. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
16. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptor for advanced glycation end products in patients with decreased renal function.
Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
[TBL] [Abstract][Full Text] [Related]
18. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men.
Safarinejad MR; Hosseini SY; Dadkhah F; Asgari MA
Clin Nutr; 2010 Feb; 29(1):100-5. PubMed ID: 19666200
[TBL] [Abstract][Full Text] [Related]
19. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
20. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
